Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

FOLFOX chemotherapy regimen

3

II.b ARDS - Acute lung injury

2
Last update : 04/05/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Fluorouracil (5-FU)
3
Oxaliplatin-based regimens
4

Publications

Organizing pneumonia with fatal outcome after adjuvant chemotherapy with FOLFOX.
Archivos de bronconeumologia 2015 Nov;51;610 2015 Nov
Hemoptysis and acute respiratory syndrome (ARDS) as delayed-type hypersensitivity after FOLFOX4 plus bevacizumab treatment.
International surgery 2013;98;445-9 2013
Drug-associated acute lung injury: a population-based cohort study.
Chest 2012 Oct;142;845-850 2012 Oct
Interstitial lung disease in a patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) for metastatic colorectal cancer.
Radiology and oncology 2012 Dec;46;360-2 2012 Dec
Oxaliplatin-induced lung toxicity. Case report and review of the literature.
Current drug safety 2012 Apr;7;179-82 2012 Apr

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies